Strategies for minimal residual disease detection: current perspectives
Giacomo Andreani, Daniela Cilloni Department of Clinical and Biological Sciences, University of Turin, Turin, Italy Abstract: Currently, the post-remission treatment in acute leukemia is based on the genetic profile of leukemic cells at diagnosis (ie, FLT3 ITD positivity) and on the level of measura...
Guardado en:
Autores principales: | Andreani G, Cilloni D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be6c2eb12ce74ebb9ab03ad515312d13 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
por: Hefazi M, et al.
Publicado: (2018) -
Complications and management of coagulation disorders in leukemia patients
por: Lad DP, et al.
Publicado: (2017) -
Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012) -
MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
por: Lim EL, et al.
Publicado: (2013) -
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)